42 related articles for article (PubMed ID: 2408732)
21. Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer.
Kato H; Morioka H; Tsutsui H; Aramaki S; Torigoe T
Cancer; 1982 Oct; 50(7):1294-6. PubMed ID: 7104971
[TBL] [Abstract][Full Text] [Related]
22. Carcinoembryonic antigen in carcinoma of the uterine cervix: antigen distribution in primary and metastatic tumors.
van Nagell JR; Hudson S; Gay EC; Donaldson ES; Hanson M; Powell DF; Goldenberg DM
Cancer; 1982 Jan; 49(2):379-83. PubMed ID: 6274508
[TBL] [Abstract][Full Text] [Related]
23. [Clinical significance of tumor associated antigen TA-4 in gynecologic tumors].
Inoue Y; Ueda G; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Nishino T; Saito J; Abe Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):919-22. PubMed ID: 3894536
[TBL] [Abstract][Full Text] [Related]
24. Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer.
Hsieh CY; Chang DY; Huang SC; Yen ML; Juang GT; Ouyang PC
Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):797-800. PubMed ID: 2592943
[TBL] [Abstract][Full Text] [Related]
25. An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinoma.
Senekjian EK; Young JM; Weiser PA; Spencer CE; Magic SE; Herbst AL
Am J Obstet Gynecol; 1987 Aug; 157(2):433-9. PubMed ID: 3475982
[TBL] [Abstract][Full Text] [Related]
26. Studies on the special tumor marker of cervical cancer of the uterus.
Kato H
Semin Surg Oncol; 1987; 3(1):55-63. PubMed ID: 3544141
[TBL] [Abstract][Full Text] [Related]
27. Uterine cervical squamous cell carcinoma with reactive multinucleated giant cells expressing cluster of differentiation 204: A case report and literature review.
Dejima M; Hashimoto H; Sasajima Y; Nomura N; Sugita M; Morikawa T
J Obstet Gynaecol Res; 2020 Oct; 46(10):2174-2178. PubMed ID: 32779321
[TBL] [Abstract][Full Text] [Related]
28. Isolated cardiac metastasis from cervical carcinoma: presentation as acute anteroseptal myocardial infarction.
Kountz DS
South Med J; 1993 Feb; 86(2):228-30. PubMed ID: 8434300
[TBL] [Abstract][Full Text] [Related]
29. The use of tumor markers in the management of patients with gynecologic carcinomas.
Berchuck A; Boente MP; Bast RC
Clin Obstet Gynecol; 1992 Mar; 35(1):45-54. PubMed ID: 1544249
[No Abstract] [Full Text] [Related]
30. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization.
Maruo T; Shibata K; Kimura A; Hoshina M; Mochizuki M
Cancer; 1985 Jul; 56(2):302-8. PubMed ID: 2408732
[TBL] [Abstract][Full Text] [Related]
31. Factors regulating SCC antigen expression in squamous cell carcinoma of the uterine cervix.
Maruo T; Yoshida S; Samoto T; Tateiwa Y; Peng X; Takeuchi S; Motoyama S
Tumour Biol; 1998; 19(6):494-504. PubMed ID: 9817979
[TBL] [Abstract][Full Text] [Related]
32. Tumor-associated antigens in gynecologic cancer.
DiSaia PJ
Clin Obstet Gynecol; 1975 Dec; 18(4):87-108. PubMed ID: 765038
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
